SCHEMBL14548908

SCHEMBL14548908

CC(=O)c1ccc2[nH]c3ccc(-c4cccc(C)n4)cc3c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.52
BRD4 O60885 1/20 0.41
PAK1 Q13153 1/20 0.41
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
HCRTR1 O43613 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ERBB2 P04626 3/20 0.40
TGFBR1 P36897 3/20 0.40
PTK6 Q13882 2/20 0.39
TLR8 Q9NR97 2/20 0.39
TLR7 Q9NYK1 2/20 0.39
PGR P06401 1/20 0.39
WEE1 P30291 1/20 0.39
TGFBR2 P37173 1/20 0.39
CYP2A6 P11509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680552 0.80 CYP2A6 (0.53) BRD4PGRCYP2A6DHFR
SCHEMBL13680472 0.79 CCR1 (0.52) BRD4ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL13418910 0.78 PTGER4 (0.47) KDM4EALDH1A1
SCHEMBL31506909 0.77 KIF11 (0.74) KIF11KMT2AKDM4EMEN1HCRTR1
SCHEMBL30366673 0.77 KIF11 (0.74) KIF11KMT2AKDM4EMEN1HCRTR1
SCHEMBL2333579 0.77 KIF11 (0.74) KIF11KMT2AKDM4EMEN1HCRTR1
SCHEMBL675071 0.74 KIF11 (0.58) KIF11KMT2AKDM4EMEN1ALDH1A1
SCHEMBL2028709 0.73 KIF11 (0.69) KIF11KMT2AKDM4EMEN1HCRTR1
SCHEMBL31244397 0.73 KIF11 (0.69) KIF11KMT2AKDM4EMEN1HCRTR1
SCHEMBL12608703 0.72 CNR2 (0.44) KDM4EALDH1A1SMN1; SMN2TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9566265-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2017-02-14 US disclosed
US-20150342927-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS INCURON, INC. 2015-12-03 US disclosed
US-9108916-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2015-08-18 US disclosed
US-20140303224-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS INCURON, LLC (US) 2014-10-09 US disclosed
US-8765738-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2014-07-01 US disclosed
EP-2356093-B1 Carbazole compounds and therapeutic uses of the compounds INCURON LLC (RU) 2013-01-09 EP disclosed
US-20110305661-A1 Carbazole Compounds and Therapeutic Uses of the Compounds INCURON, INC. 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150342927-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS MALT1, PAICS, BCL9 KIF11 2648/4885BRD4 249/4885PAK1 2353/4885
US-20110305661-A1 Carbazole Compounds and Therapeutic Uses of the Compounds MALT1, PAICS, TPMT KIF11 2736/4885BRD4 252/4885PAK1 2372/4885
US-20140303224-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS MALT1, PAICS, BCL9 KIF11 2648/4885BRD4 249/4885PAK1 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.